Otsuka Holdings
4578.T
#692
Rank
โ‚น3.509 T
Marketcap
โ‚น6,671
Share price
7.13%
Change (1 day)
63.43%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2026 (TTM): โ‚น307.78

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น334.36. In 2025 the company made an earnings per share (EPS) of โ‚น415.72 an increase over its 2024 EPS that were of โ‚น383.17.

EPS history for Otsuka Holdings from 2009 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น307.78-25.97%
2025โ‚น415.728.5%
2024โ‚น383.17153.9%
2023โ‚น150.91-15.71%
2022โ‚น179.03-6.18%
2021โ‚น190.82-24.1%
2020โ‚น251.4222.95%
2019โ‚น204.4956.13%
2018โ‚น130.97-25.11%
2017โ‚น174.9025.99%
2016โ‚น138.82-6.37%
2015โ‚น148.28
2014N/A-100%
2013โ‚น223.4018.06%
2012โ‚น189.221.01%
2011โ‚น187.3229.07%
2010โ‚น145.13-94.47%
2009โ‚น2,624